Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN107,9108,2-1,92
Msft-0,13
Nokia5,8665,921,16
IBM1,10
Mercedes-Benz Group AG57,5857,60,89
PFE0,40
14.02.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026 22:00:00
Basel Med Rg (NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (USD)
0,6302 3,29 0,02 222 435
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 15.02.2026
Popis společnosti
Obecné informace
Název společnostiBasel Medical Group Ltd
TickerBMGL
Kmenové akcie:Ordinary Shares
RICBMGL.O
ISIN-
Poslední známé roční výsledky30.06.2025
Poslední známé čtvrtletní výsledky30.06.2025
Počet zaměstnanců k 30.09.2025 77
Akcie v oběhu k 17.11.2025 18 785 750
MěnaSGD
Kontaktní informace
Ulice600 North Bridge Road
Město 
PSČ188778
ZeměSingapore
Kontatní osoba 
Funkce kontaktní osoby 
Telefon6 562 919 188

Business Summary: Basel Medical Group Ltd is a holding company, which operates through its subsidiary, Singmed Specialists Pte. Ltd. It provides a wide spectrum of general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, and more. Its services include orthopedic treatments and surgery, rehabilitative therapy, and neurosurgical care. Its orthopedic treatments and surgery include non-surgical treatments, such as medications, injections, splinting and physiotherapy, and surgical orthopedic procedures, including minimally invasive treatments to complex surgeries. Its rehabilitative therapy provides in-house physiotherapy treatments, including post-surgery rehabilitation, as well as sports therapy. Its neurosurgical care covers treatments involving spinal and brain conditions, from headaches and brain tumors to spinal issues, aneurysms and strokes.
Financial Summary: BRIEF: For the fiscal year ended 30 June 2025, Basel Medical Group Ltd revenues increased 13% to SP$11.3M. Net loss totaled SP$12.1M vs. income of SP$2.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net loss reflects Employee benefit expenses increase of 76% to SP$6.4M (expense), Other operating expense increase from SP$1.5M to SP$3.3M (expense).
Odvětvová klasifikace
TRBC2012Healthcare Facilities & Services (NEC)
MGINDUSTRYHealthcare Facilities
MGSECTORHealthcare
NAICSOffices of Physicians (except Mental Health Specialists)
NAICSOffices of Other Holding Companies
SICOffices/clinics Of Med'L Doctors
SICHolding Companies, Nec



  • Poslední aktualizace: 15.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive OfficerYen Feng Chhoa38
Chief Financial Officer, DirectorJianing Lu36
Chief Commercial OfficerBoon Chye Tan45